Samsara Therapeutics
PrivateLast Round
Grant
Oct 28, 2024
Total Funding Raised
$29.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Samsara Therapeutics is a biotechnology company that develops small-molecule autophagy activators to treat age-related neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Samsara Therapeutics Comparables
Compare Samsara Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Casma Therapeutics | 91% | |
| Libra Therapeutics | 88% | |
| PAQ Therapeutics | 88% |
Samsara Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 28, 2024 | ||||
| Grant | Nov 1, 2023 | ||||
| Grant | Jun 12, 2023 | ||||
| Grant | Oct 12, 2022 | ||||
| Seed | Dec 20, 2019 |
Samsara Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| Innovate UK | Grant |
| Target ALS | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Kite Ventures | Seed |
| CMT Research Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 33% MoM.
- Jul 25, 2026
Monthly visitors grew 1170% MoM, reaching 2.6K.
Samsara Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Samsara Therapeutics's valuation, stock price, and market status.
Is Samsara Therapeutics a public or private company?
Samsara Therapeutics is a private company.
What is the current stock price of Samsara Therapeutics?
Samsara Therapeutics is a private company, so its shares have no public market price. Caplight tracks Samsara Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Samsara Therapeutics worth (valuation)?
Valuation information for Samsara Therapeutics is not publicly available.
Can I buy Samsara Therapeutics stock?
Samsara Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Samsara Therapeutics's last funding round?
Samsara Therapeutics's most recent funding round was Grant on October 28, 2024.
Who are the main investors in Samsara Therapeutics?
Key investors in Samsara Therapeutics include The ALS Association, Innovate UK, Target ALS, The Michael J. Fox Foundation for Parkinson's Research, Kite Ventures.
Will Samsara Therapeutics IPO soon?
No public IPO plans have been announced for Samsara Therapeutics.
How can I track Samsara Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Samsara Therapeutics's shares on secondary markets.